Endoscopic conversion of sleeve gastrectomy to a new bypass method for reflux and obesity
Official title: Endoscopic Conversion of Sleeve Gastrectomy to Single Anastomosis Sleeve-ileal Bypass (SASI) for Gastroesophageal Reflux (GERD), Primary and Secondary Non-responder.
Run by Singapore Health Services · NCT06757296 · Data updated 2026-11-12
This study is testing a new, less invasive procedure to help people who haven't lost enough weight or have gained weight back after sleeve gastrectomy by converting it to a different type of bypass surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 65 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Singapore Health Services Academic / other |
| Locations | 3 sites (Singapore and 2 other locations) |
| Status | Recruiting |
| Started | February 3, 2025 |
| Main results expected | August 30, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | February 14, 2025 |
| Trial ID | NCT06757296 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 21-65 who are undergoing sleeve gastrectomy and can provide informed consent.
✕Probably not a fit
Patients with severe psychiatric illnesses, active neoplastic diseases, or significant cardiovascular conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the feasibility and effectiveness of an endoscopic procedure that converts sleeve gastrectomy to a single anastomosis sleeve-ileal bypass (SASI) using a lumen apposing metal stent (LAMS). It targets patients who have not achieved sufficient weight loss or have experienced weight regain after sleeve gastrectomy. The study proposes a less invasive, incisionless technique compared to traditional revisional laparoscopic surgeries, which carry higher risks of complications. By replicating the physiological effects of SASI, the study seeks to provide a safer alternative for patients struggling with metabolic syndrome and gastroesophageal reflux.
Why it matters
Potential benefit: If successful, this approach could provide a safer and more effective treatment option for patients with obesity and gastroesophageal reflux who have not responded to previous bariatric surgery.
How similar studies have gone: While the SASI procedure is relatively novel, similar endoscopic techniques have shown promise in other studies, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Subject must meet all the inclusion criteria to participate in this study and list each criterion. 1. Age: 21-65 years 2. Patients going for LSG at participating hospitals. 3. Able to provide informed consent Individuals below age 21 would not be recruited as this is a study in the adult population. Individuals above age 65 are excluded to minimize the procedure risk. Exclusion Criteria: 1. Patients who were breast feeding or pregnant 2. Severe psychiatric illness 3. Eating disorder 4. Active neoplastic disease 5. End-stage renal disease 6. Patients with bleeding diathesis 7. Patients with pacemakers or implantable cardiac defibrillators 8. Significant cardiovascular disease (e.g., acute myocardial infarction, congestive cardiac failure, ischemic heart disease, atrial fibrillation, sick sinus syndrome, supraventricular tachycardia) 9. Any factors likely to limit adherence to study protocol (e.g., dementia; alcohol or substance abuse; history of unreliability in medication taking or appointment keeping; significant concerns about participation in the study from spouse, significant other or family members) 10. Treatment with anti-platelet agents that could not be temporarily discontinued
Where it's running
-
Changi General Hospital
Singapore, Singapore Recruiting -
Sengkang General Hospital
Singapore, Singapore Recruiting -
Singapore General Hospital
Singapore, Singapore Recruiting
Study contacts
- Principal investigator: Chin Hong Lim, MD — Singapore General Hospital
- Study coordinator: Chin Hong Lim, MD
- Email: lim.chin.hong@singhealth.com.sg
- Phone: 62223322
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nissen‑Sleeve versus Roux‑en‑Y gastric bypass for reflux in people with severe obesity
This trial tests whether Nissen‑Sleeve gastrectomy or Roux‑en‑Y gastric bypass better controls GERD symptoms in adults who are eligible for bariatric surgery due to severe obesity.
-
Impact of Sleeve Gastrectomy on Bone and Muscle Health in Men and Women
This study is trying to see how sleeve gastrectomy affects bone and muscle health in men and women over three years.
-
Fulvic acid supplements for metabolic syndrome
This study tests whether 50 mg or 100 mg of fulvic acid daily for 12 weeks can help people with metabolic syndrome or prediabetes.
-
Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome
This study tests whether certain blood biomarkers, including asprosin and six microRNAs, differ between young women with metabolic syndrome and healthy peers.
-
15-year outcomes after sleeve gastrectomy in France
This study looks at how people who had sleeve gastrectomy have fared over 15 years to see long-term weight changes and health effects.
-
Mother and baby health after bariatric surgery in pregnancy
This study follows pregnant women who have had bariatric surgery and those who have not to see how nutrition, pregnancy health, and baby outcomes compare.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.